Purchase Order 75F40122P00512
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
- Bruker Biospin Corp, a manufacturer of scientific instruments, was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration for $1,609,000. The contract calls for Bruker Biospin Corp to provide a 600 MHz Bruker nuclear magnetic resonance spectrometer to the agency's facility in Billerica, Massachusetts by December 31, 2022. No set-aside designation was used for this procurement. Bruker Corporation is the parent company of Bruker...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a manufacturer of scientific instruments, a $398,050.00 firm-fixed-price purchase order contract to provide an NMR 400 console upgrade and deuterium probe. The contract was not set aside. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support services to various U.S. federal government agencies. This award supports the FDA's...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the procurement of a 400MHz NMR spectrometer food screening system, under solicitation FDA-RFQ-CFSAN-2024-121654. The total ceiling value of the contract is $359,990.00, with a completion date of July 4, 2025. This award is not associated with a set-aside program. Bruker Biospin Corp is a manufacturer of scientific instruments and has a...
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for $168,657.46 to provide service and maintenance for a Bruker Biospec 70/30 magnetic resonance imaging (MRI) cooler and cold head. The contract has a completion date of August 31, 2022. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and support services...
- The U.S. Department of Agriculture Agricultural Research Service awarded a Firm Fixed Price Purchase Order contract worth $184,299.25 to Bruker Biospin Corp, a manufacturer of scientific instruments, to provide a cryoplatform that can interface with the agency's existing proprietary Bruker Avance III HD Nuclear Magnetic Resonance (NMR) spectrometer. The contract has a completion date of April 30, 2023 and was awarded on September 12, 2022. Bruker Biospin Corp is a for-profit organization and...
- The U.S. Food and Drug Administration (FDA) awarded a $195,933.11 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, to acquire a comprehensive service agreement from the original equipment manufacturer (OEM) Bruker. The agreement includes preventive maintenance with two (2) helium refills per year, as well as any repairs and support for a Bruker Avance III HD 600 instrument. The award has an ultimate completion date of August 31, 2027. Bruker...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of nuclear magnetic resonance (NMR) equipment and services. The contract has a ceiling value of $1,334,738.00 and a period of performance ending on July 31, 2017. The contract was awarded on a full and open competition basis, with no set-aside designation. Bruker Biospin Corp is a manufacturer of advanced...
- Bruker Biospin Corp, a manufacturer of scientific instruments and subsidiary of Bruker Corporation, has been awarded a firm fixed price purchase order totaling $210,321.52 by the Department of Health and Human Services' Food and Drug Administration. The contract is for preventative maintenance and repair services for a Bruker Avance III 600 MHz nuclear magnetic resonance spectrometer located in Jamaica, New York through December 18, 2022. No set-aside designation was used for this award to...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a subsidiary of Bruker Corporation, a $110,097.30 firm-fixed-price purchase order to provide an automatic sample changer and compatible probe for a Bruker 400 MHz nuclear magnetic resonance (NMR) spectrometer. The award has an August 17, 2024 completion date and was made on September 16, 2022. Bruker Biospin Corp is a for-profit manufacturer of scientific instruments and equipment. The company has experience providing NMR spectrometers, upgrades, maintenance, and support services to various federal agencies, including the National Institutes of Health, Department of Veterans Affairs, and NASA. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 4/13/23 | |
| Not listed | Not listed | $110.1k | 9/16/22 |